| RPRX 1.20% 2025-09-02 USDRoyalty Pharma plc | United Kingdom | 2025-09-02 | 1.200 | 5.59 |
| RPRX 1.20% 2025-09-02 USDRoyalty Pharma plc | United Kingdom | 2025-09-02 | 1.200 | 0.00 |
| RPRX 1.20% 2025-09-02 USDRoyalty Pharma plc | United Kingdom | 2025-09-02 | 1.200 | 5.59 |
| RPRX 1.75% 2027-09-02 USDRoyalty Pharma plc | United Kingdom | 2027-09-02 | 1.750 | 3.40 |
| RPRX 1.75% 2027-09-02 USDRoyalty Pharma plc | United Kingdom | 2027-09-02 | 1.750 | 4.12 |
| RPRX 1.75% 2027-09-02 USDRoyalty Pharma plc | United Kingdom | 2027-09-02 | 1.750 | 3.40 |
| RPRX 2.15% 2031-09-02 USDRoyalty Pharma plc | United Kingdom | 2031-09-02 | 2.150 | 4.65 |
| RPRX 2.20% 2030-09-02 USDRoyalty Pharma plc | United Kingdom | 2030-09-02 | 2.200 | 4.50 |
| RPRX 2.20% 2030-09-02 USDRoyalty Pharma plc | United Kingdom | 2030-09-02 | 2.200 | 4.47 |
| RPRX 2.20% 2030-09-02 USDRoyalty Pharma plc | United Kingdom | 2030-09-02 | 2.200 | 4.50 |
| RPRX 3.30% 2040-09-02 USDRoyalty Pharma plc | United Kingdom | 2040-09-02 | 3.300 | 5.55 |
| RPRX 3.35% 2051-09-02 USDRoyalty Pharma plc | United Kingdom | 2051-09-02 | 3.350 | 5.73 |
| RPRX 3.55% 2050-09-02 USDRoyalty Pharma plc | United Kingdom | 2050-09-02 | 3.550 | 5.00 |
| RPRX 3.55% 2050-09-02 USDRoyalty Pharma plc | United Kingdom | 2050-09-02 | 3.550 | 5.80 |
| RPRX 3.55% 2050-09-02 USDRoyalty Pharma plc | United Kingdom | 2050-09-02 | 3.550 | 5.00 |
| RPRX 4.45% 2031-03-25 USDRoyalty Pharma plc | United Kingdom | 2031-03-25 | 4.450 | 4.59 |
| RPRX 5.20% 2035-09-25 USDRoyalty Pharma plc | United Kingdom | 2035-09-25 | 5.200 | 5.17 |
| RPRX 5.95% 2055-09-25 USDRoyalty Pharma plc | United Kingdom | 2055-09-25 | 5.950 | 5.90 |
